Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection

Viral Immunology

Volumn 24, Issue 2, 2011, Pages 119-129

  Ayers, Chris L ^a   Firan, Mihail ^a   Pillai, Vinodh ^a   Lee, William M ^a   Karandikar, Nitin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; VIRUS RNA;

ADULT; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MITOGENICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS ACTIVATION; VIRUS CELL INTERACTION;

ADULT; ANTIGENS, CD4; APOPTOSIS; B-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

HEPATITIS C VIRUS;

EID: 79953235883     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0077     Document Type: Article

References (46)

1. Altomonte M, Montagner R, Pucillo C, and Maio M: Trig-gering of target of an antiproliferative antibody-1 (TAPA-1/CD81) up-regulates the release of tumour necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY. Scand J Immunol 1996;43:367-373. (Pubitemid 26106151)
2. Averill L, Lee WM, and Karandikar NJ: Differential dys-function in dendritic cell subsets during chronic HCV infection. Clin Immunol 2007;123:40-49. (Pubitemid 46401508)
3. Bain C, Fatmi A, Zoulim F, et al.: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001;120:512-524. (Pubitemid 32147649)
4. Barnes E, Lauer G, Walker B, and Klenerman P: T cell fail-ure in hepatitis C virus infection. Viral Immunol 2002;15: 285-293. (Pubitemid 34651532)
5. Bassett SE, Brasky KM, and Lanford RE: Analysis of hepa-titis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998;72:2589-2599. (Pubitemid 28175492)
6. Boettler T, Spangenberg HC, Neumann-Haefelin C, et al.: T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005;79:7860-7867. (Pubitemid 40756821)
7. Bouffard P, Hayashi PH, Acevedo R, et al.: Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992;166:1276-1280.
8. Bowen DG, and Walker CM: Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005;436:946-952. (Pubitemid 41191670)
9. Cabrera R, Tu Z, Xu Y, et al.: An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071. (Pubitemid 39425561)
10. Cooper S, Erickson AL, Adams EJ, et al.: Analysis of a suc-cessful immune response against hepatitis C virus. Immunity 1999;10:439-449. (Pubitemid 29205480)
11. Crawford MP, Yan SX, Ortega SB, et al.: High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004;103:4222-4231. (Pubitemid 38685367)
12. Crotta S, Stilla A, Wack A, et al.: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002;195:35-41. (Pubitemid 34074494)
13. Ebinuma H, Nakamoto N Li Y, et al.: Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J. Virol 2008;82:5043-5053. (Pubitemid 351657064)
14. Gates JA, Post JJ, Kaldor JM, et al.: Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health 2004;81:448-452. (Pubitemid 39128280)
15. Gerlach JT, Diepolder HM, Jung MC, et al.: Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117: 933-941. (Pubitemid 29468237)
16. Kato T, Date T, Miyamoto M, et al.: Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003;125:1808-1817. (Pubitemid 37500445)
17. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, et al.: Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000;106:1239-1249.
18. Lanford RE, Chavez D, Chisari FV, and Sureau C: Lack of detection of negative-strand hepatitis C virus RNA in pe-ripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcrip-tase PCR. J Virol 1995;69:8079-8083.
19. Lanford RE, Sureau C, Jacob JR, et al.: Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR Virology 1994;202: 606-614. (Pubitemid 24254873)
20. Larsson M, Babcock E, Grakoui A, et al.: Lack of phenotypic and functional impairment in dendritic cells from chim-panzees chronically infected with hepatitis C virus. J Virol 2004;78:6151-6161. (Pubitemid 38715913)
21. Lechner F, Wong DK, Dunbar PR, et al.: Analysis of suc-cessful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512. (Pubitemid 30257347)
22. Levy S, Todd SC, Maecker HT: CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998;16:89-109. (Pubitemid 28183360)
23. Machida K, Cheng KT, Pavio N, et al.: Hepatitis C virus E2-CD81 interaction induces hypermutation of the immuno-globulin gene in B cells. J Virol 2005;79:8079-8089. (Pubitemid 40853511)
24. Manigold T, Shin EC, Mizukoshi E, et al.: Foxp3+ CD4+ CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C Blood 2006; 107:4424-4432. (Pubitemid 43801369)
25. Mayo MJ: Extrahepatic manifestations of hepatitis C infec-tion. Am J Med Sci 2003;325:135-148.
26. Montes CL, Acosta-Rodriguez EV, Merino MC, et al.: Poly-clonal B cell activation in infections: infectious agents' dev-ilry or defense mechanism of the host? J Leukoc Biol 2007;82:1027-1032. (Pubitemid 350133497)
27. Muller HM, Pfaff E, Goeser T, et al.: Peripheral blood leu-kocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993;74:669-676. (Pubitemid 23113370)
28. Pal S, Sullivan DG, Kim S, et al.: Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: impli-cations of HCV lymphotropism Gastroenterology 2006;130: 1107-1116.
29. Pillai V, and Karandikar NJ: Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? Immunol Lett 2007;114:9-15. (Pubitemid 47625594)
30. Rosa D, Saletti G, De Gregorio E, et al.: Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hep-atitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005;102:18544-18549. (Pubitemid 43011262)
31. Rushbrook SM, Ward SM, Unitt E, et al.: Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005;79: 7852-7859. (Pubitemid 40756820)
32. Sarobe P, Lasarte JJ, Casares N, et al.: Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 2002;76:5062-5070. (Pubitemid 34441711)
33. Schmidt WN, Klinzman D, LaBrecque DR, et al.: Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells. J Med Virol 1995;47:153-160.
34. Schmidt WN, Wu P, Han JQ, et al.: Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J Infect Dis 1997;176:20-26. (Pubitemid 27272847)
35. Suarez F, Lortholary O, Hermine O, and Lecuit M: Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107:3034-3044.
36. Sugimoto K, Ikeda F, Stadanlick J, et al.: Suppression of HCV-specific T cells without differential hierarchy demon-strated ex vivo in persistent HCV infection. Hepatology 2003;38:1437-1448. (Pubitemid 37466970)
37. Tseng CT, and Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002;195:43-49. (Pubitemid 34074495)
38. Tsubouchi E, Akbar SM, Murakami H, et al.: Isolation and functional analysis of circulating dendritic cells from hepa-titis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004;137:417-423. (Pubitemid 39013090)
39. Ulsenheimer A, Gerlach JT, Gruener NH, et al.: Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C Hepatology 2003;37:1189-1198. (Pubitemid 36538697)
40. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al.: Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006;116:2423-2433. (Pubitemid 44330141)
41. Wakita T, Pietschmann T, Kato T, et al.: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-796. (Pubitemid 41021213)
42. Wang JT, Sheu JC, Lin JT, et al.: Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 1992;166:1167-1169.
43. Willems M, Moshage H, and Yap SH: PCR and detection of negative HCV RNA strands. Hepatology 1993;17:526. (Pubitemid 23072832)
44. Wong DK, Dudley DD, Afdhal NH, et al.: Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998;160:1479-1488. (Pubitemid 28093451)
45. Zeuzem S, Feinman SV, Rasenack J, et al.: Peginterferon alfa-2a in patients with chronic hepatitis C N Engl J Med 2000; 343:1666-1672.
46. Zignego AL, Macchia D, Monti M, et al.: Infection of pe-ripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-386.